Xiangxue Pharmaceutical (300147) — Cash Flow Quality Index
Xiangxue Pharmaceutical (300147) has a Cash Flow Quality Index of 1.00x as of March 2023. Operating cash flow of CN¥8.28 Million exceeds net income of CN¥8.28 Million, indicating high earnings quality where cash backs reported profits. Explore 300147 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Xiangxue Pharmaceutical Cash Flow Quality Index (2007–2020)
Historical Cash Flow Quality Index for Xiangxue Pharmaceutical across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 300147 cash flow conversion.
Annual Cash Flow Quality Index for Xiangxue Pharmaceutical (2007–2020)
Year-by-year earnings quality comparison for Xiangxue Pharmaceutical.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 1.81x | CN¥257.18 Million | CN¥141.80 Million | ▲ +175.6% |
| 2019 | 0.66x | CN¥83.02 Million | CN¥126.13 Million | ▼ -36.5% |
| 2018 | 1.04x | CN¥91.24 Million | CN¥87.97 Million | ▲ +6.2% |
| 2017 | 0.98x | CN¥109.53 Million | CN¥112.13 Million | ▼ -51.9% |
| 2016 | 2.03x | CN¥198.48 Million | CN¥97.64 Million | ▲ +156.4% |
| 2015 | 0.79x | CN¥159.89 Million | CN¥201.65 Million | ▲ +3.7% |
| 2014 | 0.76x | CN¥165.58 Million | CN¥216.54 Million | ▼ -60.2% |
| 2013 | 1.92x | CN¥328.37 Million | CN¥171.09 Million | ▲ +76.2% |
| 2012 | 1.09x | CN¥118.91 Million | CN¥109.17 Million | ▲ +212.8% |
| 2011 | 0.35x | CN¥29.55 Million | CN¥84.88 Million | ▼ -42.2% |
| 2010 | 0.60x | CN¥45.47 Million | CN¥75.42 Million | ▼ -32.1% |
| 2009 | 0.89x | CN¥46.19 Million | CN¥52.06 Million | ▼ -40.6% |
| 2008 | 1.49x | CN¥55.72 Million | CN¥37.28 Million | ▼ -65.7% |
| 2007 | 4.35x | CN¥138.02 Million | CN¥31.69 Million | — |